Cover Image

Correction to “Minimizing prescribing errors: A phenomenological exploration of the views and experiences of independent prescribing pharmacists”

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	British Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improving prescribing outcomes in undergraduate medical training
by: Chee Yeen Fung, et al.
Published: (2024)

Assessment and evaluation of prescribing competences: A systematic review and recommendations
by: John C. McLachlan, et al.
Published: (2024)

Safe and supportive prescribing in transgender and non‐binary patients with cancer
by: Mariachiara D'Elia, et al.
Published: (2024)

Understanding factors that influence the drug choice of prescribers: A Q‐methodology study
by: Mariëlle G. Hartjes, et al.
Published: (2025)

A scoping review of quality prescribing indicators, rules and criteria for primary care
by: James Nind, et al.
Published: (2026)

Prescribing variation across Europe: Insights into prescribing practices and educational needs
by: Mariëlle G. Hartjes, et al.
Published: (2025)

“Doctor, would it surprise you if there were prescribing errors in this patient's medication?” Identifying eligible patients for in‐hospital pharmacotherapeutic stewardship: A matched case‐control study
by: Rashudy F. Mahomedradja, et al.
Published: (2024)

Factors influencing physicians’ antimicrobial prescribing decisions: A systematic review of qualitative studies
by: Savannah Reali, et al.
Published: (2025)

The prevalence of polypharmacy in older Europeans: A multi‐national database study of general practitioner prescribing
by: Marion Bennie, et al.
Published: (2024)

Paediatric rare diseases: Can large language models assist off‐label prescribing?
by: Anna Flamigni, et al.
Published: (2025)

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society
by: Dagan O. Lonsdale, et al.
Published: (2026)

The use of C‐reactive protein testing and antibiotic prescribing in Italy: A population‐based study in primary care
by: Francesco Lapi, et al.
Published: (2024)

Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: Insights from multi‐metric evaluation
by: Gabriela Rolová, et al.
Published: (2025)

Antidepressant and antipsychotic prescribing in patients with type 2 diabetes in Scotland: A time‐trend analysis from 2004 to 2021
by: Charlotte R. L. Greene, et al.
Published: (2024)

Prevalence and impact of prescribing cascades in community‐dwelling adults: Longitudinal analysis of the Irish longitudinal study on ageing (TILDA)
by: Ann Sinéad Doherty, et al.
Published: (2025)

Association of state‐level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia
by: Ting Xia, et al.
Published: (2024)

Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards
by: Antonio De Vincentis, et al.
Published: (2024)

Gabapentinoids in Ireland 2010 to 2020: An observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and postmortem toxicology
by: Louise Durand, et al.
Published: (2024)

Bridging the gap between clinical pharmacology and rational drug prescribing 2.0: An up‐date after 30 years
by: Erik M. Donker, et al.
Published: (2024)

The impact of a preprescribing formative assessment on learning in final‐year medical students using hospital inpatient electronic prescribing systems
by: Kellie A. Charles, et al.
Published: (2025)

Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data
by: Helena Cangadis‐Douglass, et al.
Published: (2024)

Developing medication independence: The experience of UK teenagers
by: Holly Hutchins, et al.
Published: (2026)

Long‐term prescribed opioid use after hospitalization or emergency department presentation among opioid naïve adults (2014–2020)—A population‐based descriptive cohort study
by: Malcolm B. Gillies, et al.
Published: (2024)

Infringement of clinical pharmacist's authority
by: Fitriana Mawardi, et al.
Published: (2024)

Correction to “Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures”
Published: (2026)

European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data
by: Rosa Gonzalez‐Quevedo, et al.
Published: (2025)

Determinants of pharmacists' confidence to participate in antimicrobial stewardship: A confirmatory factor analysis
by: Naomi Weier, et al.
Published: (2024)

Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings
by: Monica Jung, et al.
Published: (2026)

Practice, knowledge and attitude of physicians and pharmacists towards the spontaneous reporting system of adverse drug reactions in Switzerland
by: Fiona A. Strobel, et al.
Published: (2026)

Exploring the complexities of drug formulation selection, storage, and shelf‐life for exploration spaceflight
by: Vernie R. Daniels, et al.
Published: (2024)

Minimal impact of pregnancy on rilpivirine pharmacokinetics: A POPPK approach
Published: (2024)

Interindividual variability in olanzapine steady‐state concentrations in Chinese: exploring single nucleotide polymorphisms of metabolic enzymes
by: Zhou Wan, et al.
Published: (2025)

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects
by: James Goodman, et al.
Published: (2025)

Temporal effects of errors in estimating kidney function after critical illness on drug dosing categories
by: Ryusei Mikami, et al.
Published: (2025)

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment
by: Milad Sadreghaemy, et al.
Published: (2025)

Strategies employed and experiences associated with the implementation of pharmaceutical services and interventions in geriatric wards: A scoping review
by: Alan Maicon de Oliveira, et al.
Published: (2024)

Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist
by: Sonia Guleria, et al.
Published: (2024)

Correction to “Naltrexone‐bupropion (Mysimba) in management of obesity: A systematic review and meta‐analysis of unpublished clinical study reports.”
by: Igho J. Onakpoya
Published: (2024)

Correction to “Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice”
Published: (2025)

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience
by: Juliette A. van den Noort, et al.
Published: (2025)